| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chf Clinical Develop Ofcr | EVP, Chf Clinical Develop Offc
1 company
Schneider Eugene is an EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $83.45 | $515,629.52 | -8.1% | -9.6% | - | |
| Sep 3, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sale+OE | 19,658 | $60.81 | $1,195,420.87 | -15.1% | +34.4% | - | |
| Aug 4, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sell | 9,549 | $42.80 | $408,701.02 | -15.6% | +69.5% | - | |
| Jan 31, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sell | 1,484 | $32.20 | $47,779.90 | -2.4% | -0.6% | +159.2% | |
| Jan 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sale+OE | 6,523 | $32.79 | $213,889.17 | -10.0% | -12.2% | +136.5% | |
| Feb 2, 2024 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sell | 2,071 | $49.59 | $102,700.89 | -4.0% | -13.4% | -35.9% | |
| Jan 17, 2024 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sale+OE | 5,482 | $50.42 | $276,385.99 | -10.3% | -19.0% | -37.1% | |
| Jan 12, 2024 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sale+OE | 8,000 | $53.50 | $427,999.20 | -17.3% | -20.6% | -37.5% | |
| Dec 26, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sale+OE | 25,000 | $51.46 | $1,286,575.00 | -40.9% | -14.4% | -29.2% | |
| Feb 6, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Clinical Develop Ofcr | Sell | 1,413 | $40.67 | $57,464.17 | -5.4% | -13.1% | +21.3% |